IQVIA is trading at $235.00 (+10.21%) following a strong Q2 2026 earnings beat and an upward revision to its full-year outlook.

  • The company reported revenue of $4.37 billion and adjusted EPS of $3.15, both exceeding analyst estimates, while R&D Solutions net new bookings reached a record $3.15 billion.
  • Management raised its 2026 adjusted EPS guidance to a range of $12.80–$13.00, signaling continued growth momentum.